HEB $0.352 candle breakout PR
Post# of 74
Posted On: 12/09/2013 12:29:06 PM
HEB $0.352 candle breakout PR
Shares Outstanding 167,686,551 a/o Nov 01, 2013
Float Not Available
Hemispherx: FDA Approves Expansion Of Ampligen/FluMist Intranasal Trial
12/9/2013 8:29:00 AM - RTT News
FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses
12/9/2013 8:00:00 AM - GlobeNewswire
Shares Outstanding 167,686,551 a/o Nov 01, 2013
Float Not Available
Hemispherx: FDA Approves Expansion Of Ampligen/FluMist Intranasal Trial
12/9/2013 8:29:00 AM - RTT News
FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses
12/9/2013 8:00:00 AM - GlobeNewswire
(0)
(0)AIM ImmunoTech Inc. (AIM) Stock Research Links
Scroll down for more posts ▼